MCK McKesson Corporation
Company Analysis
Latest News
McKesson closes $1.25B Apollo deal, paving way for medical unit spinoff
McKesson Corporation completed its transaction with Apollo Funds on June 1, 2026. Apollo invested $1.25 billion for a minority stake in the Medical-Surgical...
McKesson Medical Unit Prices $2.25 Billion Loan, Targeting Standalone IPO
McKesson Corporation’s Medical-Surgical Solutions (MMS) unit priced a $2.25 billion leveraged loan on June 3, 2026. The financing establishes an independent...
McKesson Gains $1.65 Billion Stake From Norway’s Sovereign Wealth Fund
Norges Bank established a new position in McKesson Corporation according to recent 13F regulatory filings. The sovereign wealth fund purchased 2,012,870...
McKesson Corporation Q1 2026 Earnings Preview: What Analysts Expect on May 13, 2026
For the reporting period ending March 31, 2026, analysts expect McKesson to post consensus revenue of $101.40 billion and an adjusted EPS of $11.56, while the...
McKesson's fourth quarter fiscal 2026 EPS of $11.69 beat estimates, driven by strong growth in its Oncology segment.
McKesson reported fourth quarter fiscal 2026 revenues of $96.3 billion, a 6% increase year-over-year, with adjusted EPS growing 16% to $11.69. For the full...
McKesson Corporation Q1 2026 Earnings Preview: What Analysts Expect on May 07, 2026
McKesson is expected to report Q1 2026 revenue of $101.61 billion and EPS of $11.56, with the current stock price of $807.85 trading significantly below the...